Curis
CRIS
#10237
Rank
NZ$25.91 M
Marketcap
NZ$2.00
Share price
-10.08%
Change (1 day)
-66.76%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.34. In 2024 the company made an earnings per share (EPS) of NZ-$12.15 an increase over its 2023 EPS that were of NZ-$15.58.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-47.45%
2024NZ-$12.15-22.06%
2023NZ-$15.58-26.25%
2022NZ-$21.1322.3%
2021NZ-$17.28-25.37%
2020NZ-$23.15-30.93%
2019NZ-$33.52-2.02%
2018NZ-$34.21
2016NZ-$77.75-10%
2015NZ-$86.39138.1%
2014NZ-$36.2840%
2013NZ-$25.92-25%
2012NZ-$34.5666.67%
2011NZ-$20.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
NZ$4.11-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.44-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.62-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.84-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.97-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.13-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.42 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA